Physician profile
Joseph Jeppson
NPI 1063682672
$1,871.59
in general payments reported to CMS, 2019-2025
25 companies · $396 in 2025
The $396 reported for 2025 was more than what 87% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2020: $62.89 · 2021: $233 · 2022: $350 · 2023: $130 · 2024: $319 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $844.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $906.90 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $122.45 | 2019-2023 | Farxiga, Breztri |
| United Therapeutics Corporation | $116.82 | 2024 | |
| Novartis Pharmaceuticals Corporation | $82.65 | 2019-2022 | |
| Boston Scientific Corporation | $75.28 | 2025 | Artisan, General - Pain Management |
| Dexcom, INC. | $68.40 | 2021-2025 | Dexcom G6 Transmitter |
| Medtronic Vascular, INC. | $49.69 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $49.11 | 2022 | |
| Amarin Pharma, INC. | $46.64 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.97 | 2019 | |
| Janssen Pharmaceuticals, INC | $38.09 | 2021-2024 | Spravato |
| Biohaven Pharmaceuticals, INC. | $34.44 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $25.50 | 2019 | |
| Abbott Laboratories | $24.96 | 2019 | |
| Mimedx Group, INC. | $23.99 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22.90 | 2021 | |
| Nevro Corp. | $22.36 | 2022 | |
| Sunovion Pharmaceuticals INC. | $19.32 | 2019 | |
| Urgo Medical North America, LLC | $19.02 | 2024 | Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Sanofi Pasteur INC. | $18.75 | 2023 | |
| Pfizer INC. | $15.09 | 2019 | |
| Integra Lifesciences Corporation | $14.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.69 | 2019 | |
| Vertiflex, INC. | $11.80 | 2019 | |
| Bsn Medical INC | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Jeppson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.